Also known as Coreg
Carvedilol is a nonselective beta blocker/alpha-1 blocker indicated in the treatment of mild to severe congestive heart failure (CHF). It is marketed under various trade names including Carvil (Zydus Cadila), Coreg (GSK), Dilatrend (Roche), Eucardic (Roche), and Carloc (Cipla) as a generic drug (as of September 5, 2007 in the U.S.), and as a controlled-release formulation, marketed in the US as Coreg CR (GSK). Carvedilol was discovered by Robert R. Ruffolo, Jr. It has had a significant role in the treatment of congestive heart failure.Source: Wikipedia
Estimated Total Cost: $16.49 for an average of 28 days supply
Patients are most commonly prescribed carvedilol to treat heart failure, coronary atherosclerosis, cardiomyopathy, and atrial fibrillation.